Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated...

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Epidermal growth factor (EGF) signaling is crucial for cell growth and differentiation.
• Receptor-mediated endocytosis internalizes EGF-receptor (EGFR) complexes for degradation.
• The specific proteases involved in endosomal EGF and EGFR degradation remain incompletely understood.

Purpose of the Study:

• To identify the key protease responsible for epidermal growth factor (EGF) and EGF receptor (EGFR) degradation within rat liver endosomes.
• To elucidate the sequential proteolytic processing of internalized EGF-EGFR complexes.
• To investigate the functional consequences of inhibiting this proteolytic pathway.

Main Methods:

• High-performance liquid chromatography (HPLC) and mass spectrometry for identifying EGF cleavage sites.
• Nondenaturing immunoprecipitation and cross-linking to identify proteolytic enzymes.
• Immunoblotting to assess EGFR degradation and tyrosine phosphorylation status in vitro and in vivo.
• Treatment with cathepsin-B proinhibitor CA074-Me.

Main Results:

• EGF is sequentially cleaved by endosomal proteases, primarily at the C-terminal Glu(51)-Leu(52) bond.
• The major proteolytic activity responsible for EGF degradation was identified as the cysteine protease cathepsin-B.
• Cathepsin-B inhibition (using CA074-Me) prevented both EGF and EGFR degradation in endosomes.
• Inhibition of cathepsin-B preserved EGFR tyrosine phosphorylation and SHC phosphorylation within endosomes.

Conclusions:

• Cathepsin-B plays a critical role in the sequential degradation of both EGF ligand and EGFR within endosomes.
• This pathway represents a novel mechanism for regulating EGF signaling termination.
• Targeting cathepsin-B may offer a therapeutic strategy to modulate EGFR signaling in specific contexts.